Intratumoral CD8+ Cytotoxic Lymphocyte Is a Favorable Prognostic Marker in Node-Negative Breast Cancer
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference38 articles.
1. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer;A Goldhirsch;Ann Oncol,2009
2. A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin Kappa C as a compatible prognostic marker in human solid tumor;M Schmidt;Clin Cancer Res,2012
3. Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and negative cancers;G Bianchini;J Clin Oncol,2010
4. T-cell metagene predicts a favorable prognosis in estrogen-negative and HER-2 positive breast cancer;A Rody;Breast Cancer Res,2009
5. Natural killer (NK): dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity;SC Lee;Immunol Res,2011
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx;Journal for ImmunoTherapy of Cancer;2023-11
2. Soluble PD-L1 as a diagnostic and prognostic biomarker in resectable gastric cancer patients;Gastric Cancer;2023-09-05
3. The Peritumoral CD8+/FOXP3+ Cell Ratio Has Prognostic Value in Triple-negative Breast Cancer;Applied Immunohistochemistry & Molecular Morphology;2023-08-25
4. Prognostic value of CD8+ tumor‑infiltrating T cells in patients with breast cancer: A systematic review and meta‑analysis;Oncology Letters;2022-12-08
5. Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy—A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study;Cancers;2022-11-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3